Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
09/2010
09/01/2010CN101817819A 5-alkoxy-tetrazo[1,5-a]qualone derivative and pharmaceutically acceptable salt thereof serving as antidepressants
09/01/2010CN101817815A Compounds with antibacterial activity
09/01/2010CN101817787A Androgen receptor antagonist for resisting prostate cancer
09/01/2010CN101337928B Quinoline compounds, synthesizing method, applications in synthesis of alkaloid of camptothecins
09/01/2010CN101074229B 7-azaindirubin and 7-azaisoindigo derivative production and pharmaceutical use
08/2010
08/31/2010USRE41614 Synthetic analogs of ecteinascidin-743
08/31/2010US7786307 suchas N-(4(S)-amino-5(S)-hydroxy-2(S)-isopropyl-6-piperidin-1-ylhexyl)-2-(3-methoxypropoxy)benzamide dihydrochloride, used for the treatment of hypertension, cardiovasculr disorders, complications owing to diabetes, vision deffects, hyperaldosteronism, states of anxiety and cognitive disorders
08/31/2010US7786305 Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity
08/31/2010US7786304 Process for the preparation of eszopiclone
08/31/2010US7786177 Phenylalanine enamide derivatives
08/31/2010US7786162 Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof
08/31/2010US7786135 Substituted pyrroline kinase inhibitors
08/31/2010US7786131 Anticancer agents; restenosis; atherosclerosis; skin disorders
08/31/2010US7786123 Indolylmaleimide derivatives
08/31/2010US7786113 Heterocyclic carbamate derivatives, their manufacture and use as pharmaceutical agents
08/31/2010CA2447779C Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]-indole derivatives as prostaglandin d2 receptor antagonists
08/26/2010WO2010096722A1 3-oxo-2, 3-dihydro- [1,2, 4] triazolo [4, 3-a]pyridines as soluble epoxide hydrolase (seh) inhibitors
08/26/2010WO2010095767A1 Pyrimidin-4(3h)-one derivatives
08/26/2010WO2010095765A1 Ring compound
08/26/2010WO2010095042A2 Pyridocarbazole type compounds and applications thereof
08/26/2010WO2010094956A1 Triazolopyridine derivatives as p38 map kinase inhibitors
08/26/2010WO2010094695A1 Pyrimido [5,4-d] pyrimidine derivatives for the inhibition of tyrosine kinases
08/26/2010WO2010094647A1 Novel substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as gamma secretase modulators
08/26/2010WO2010094622A1 3, 3' -spiroindolinone derivatives as anticancer agents
08/26/2010WO2010094405A1 Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereof
08/26/2010US20100217001 Method for producing pyrazole fused ring derivative
08/26/2010US20100217000 Process for the Preparation of Thiazolopyrimidines
08/26/2010US20100216994 Use of novel compound having affinity for amyloid, and process for production of the same
08/26/2010US20100216988 Regioselective metal catalyzed synthesis of annelated benzimidazoles and azabenzimidazoles
08/26/2010US20100216834 Hiv integrase inhibitors
08/26/2010US20100216833 Tetrahydrocarbazoles and derivatives
08/26/2010US20100216821 Benzimidazoles With A Hetero Spiro-Decane Residue As NPY-Y5 Antagonists
08/26/2010US20100216814 Pyrido[4,3-b]indoles containing rigid moieties
08/26/2010US20100216803 Ornithine derivative
08/26/2010US20100216790 Imidazopyridine-derivatives as inducible no-synthase inhibitors
08/26/2010US20100216789 Rho-kinase inhibitors
08/26/2010US20100216786 New compounds
08/26/2010US20100216780 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use
08/26/2010US20100216779 Imidazopyridine Kinase Inhibitors
08/26/2010US20100216777 Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases and conditions
08/26/2010US20100216773 Phenanthroindolizidine analogues
08/26/2010US20100216769 Substituted glycinamides, process for their manufacture and use thereof as medicaments
08/26/2010US20100216768 N-substituted azaindoles and methods of use
08/26/2010US20100216765 Kinase inhibitors
08/26/2010US20100216763 Heteroaryl Amide Derivatives
08/26/2010US20100216760 Novel compounds as cannabinoid receptor ligands
08/26/2010US20100216726 Substituted-Quinoxaline-Type Piperidine Compounds and the Uses Thereof
08/26/2010US20100216694 Antidiabetic tricyclic compounds
08/26/2010CA2753010A1 Pyridocarbazole type compounds and applications thereof
08/26/2010CA2752693A1 Triazolopyridine derivatives as p38 map kinase inhibitors
08/26/2010CA2752603A1 Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereof
08/26/2010CA2752265A1 Pyrimido [5,4-d] pyrimidine derivatives for the inhibition of tyrosine kinases
08/26/2010CA2751767A1 3,3'-spiroindolinone derivatives as anticancer agents
08/26/2010CA2751244A1 Pyrimidin-4(3h)-one derivatives
08/26/2010CA2749495A1 Novel substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as gamma secretase modulators
08/25/2010EP2220087A1 Enantiomerically enriched imidazoazepinone compounds
08/25/2010EP2220086A2 Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as active agent
08/25/2010EP2220085A1 Fluoroalkyl tetrabenazine carbinol compounds as imaging agents and probes
08/25/2010EP2220084A1 Inhibitors of human immunodeficiency virus replication
08/25/2010EP2220083A2 Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
08/25/2010EP2220068A1 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors
08/25/2010EP2220048A2 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
08/25/2010EP2078017B1 Fluorinated catharanthine derivatives, their preparation and their utilisation as vinca dimeric alkaloid precursors
08/25/2010EP1987033B1 Diazabicycloalkane derivatives and their medical use
08/25/2010EP1931641B1 NOVEL 4-CYANO, 4-AMINO, AND 4-AMINOMETHYL DERIVATIVES OF PYRAZOLO[1,5-a]PYRIDINES, PYRAZOLO[1,5-c]PYRIMIDINES AND 2H-INDAZOLE COMPOUNDS AND 5-CYANO, 5-AMINO, AND 5-AMINOMETHYL DERIVATIVES OF IMIDAZO[1,2-a]PYRIDINES, AND IMIDAZO[1,5-a]PYRAZINES COMPOUNDS AS CYCLIN DEPENDENT KINASE INHI
08/25/2010EP1641792B1 Pyrrolodihydroisoquinolines as pde10 inhibitors
08/25/2010EP1620082B9 Medical use of inhibitors of glutaminyl and glutamate cyclases for treating alzheimer's disease and down syndrome
08/25/2010EP1551834B1 Substituted quinazolinone compounds
08/25/2010EP1517892B1 Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof
08/25/2010EP1515969B1 Spiroindolinepiperidine derivatives
08/25/2010EP1339402B1 Azaphenanthridone derivatives and their use as parp inhibitors
08/25/2010CN101815718A Pyridine derivatives and methods of use thereof
08/25/2010CN101815716A Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1
08/25/2010CN101815715A Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics
08/25/2010CN101815712A Pyrazole compounds and their use as RAF inhibitors
08/25/2010CN101812078A Heterocyclic dihydropyridine compound and synthesis method thereof
08/25/2010CN101812063A Alpha-naphthalenesulfonamide base quintuple heterocyclic compound and anti-tumor activity thereof
08/25/2010CN101812062A Novel method for preparing important intermediate of minodronate
08/25/2010CN101018788B Pyrrolo[3,2-c]pyridine derivatives and processes for the preparation thereof
08/24/2010US7781628 in which an organic thin film layer comprising a single layer or plural layers including at least a light emitting layer is sandwiched between a cathode and an anode; high luminous efficiency
08/24/2010US7781583 Synthesis of 2-(pyridin-2-ylamino)-pyrido[2,3-d] pryimidin-7-ones
08/24/2010US7781454 Substituted indazoles, benzotriazoles, and related bicyclic compounds; HIV (human immunodeficiency virus) reverse transcriptase inhibitors; delays onset of AIDS or AIDS related complex
08/24/2010US7781453 Used as nitric oxide synthase inhibitors; treating acute inflammatory disease with such as 2-[2-(2-amino-4-methylpyridin-6-yl)ethyl]-3H-imidazo[4,5-b]pyridine
08/24/2010US7781452 such as 5-(4-Fluorophenoxy)-2-(((4-methoxy-3-methyl-2-pyridinyl)methyl)sulfinyl)-3H-imidazo[4,5-b]pyridine, useful as a gastric acid secretion inhibitor, for the treatment of gastroesophageal reflux or ulcers; antisecretory agents
08/24/2010US7781450 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-(2-chlorophenyl)-4-[1-(3-hydroxypropyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1H-pyrrole-2,5-dione, used for treating cardiovascular, skin, nervous system disorders and immunological disorders, diabetes, inflammatory diseases and cancer
08/24/2010US7781443 Tetrahydronaphthyridine derivatives and a process for preparing the same
08/24/2010US7781427 cyclization of a 1,4-benzodiazepine with cyclopentene. in a diels-alders reaction to give a decahydrocyclopenta[c][1,4]diazepino[6,7,1-ij]quinoline, then resolving to form diastereomeric salts and dimer impurities; neuroleptic and dietetic agents
08/24/2010CA2391915C 3-phenyl-3,7-diazabicyclo[3.3.1]nonane compounds, process for their preparation and medicaments containing these compounds
08/24/2010CA2329320C Chlorin and bacteriochlorin-based aminophenyl dtpa and n2s2 conjugates for mr contrast media and radiopharmaceuticals
08/24/2010CA2302226C Camptothecin analogs and methods of preparation thereof
08/19/2010WO2010093706A2 Chemically programmed vaccination
08/19/2010WO2010093425A1 Histamine h3 inverse agonists and antagonists and methods of use thereof
08/19/2010WO2010092489A1 Derivatives of azaindoles as inhibitors of protein kinases abl and src
08/19/2010WO2010092340A1 Fused pyridine and pyrazine derivatives as kinase inhibitors
08/19/2010WO2010092181A1 Heterocyclic compounds, pharmaceutical compositions containing them, and their use as inhibitors of the glycine transporter 1
08/19/2010WO2010092111A2 Compounds for non-invasive measurement of aggregates of amyloid peptides
08/19/2010WO2010092041A1 [1, 2, 4] triazolo [1, 5 -a] pyridines as kinase inhibitors
08/19/2010WO2010092015A1 Urea triazololo [1, 5-a] pyridine derivatives as pi3k inhibitors
08/19/2010WO2010091996A1 2-morpholino-pyrido[3,2-d]pyrimidines
08/19/2010WO2010091979A1 Spiroindolinone pyridine derivative
1 ... 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 ... 646